DOCSLIB.ORG

Addendum to the Keystone 65 Preferred HMO Provider/Pharmacy Directory 2017

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Addendum to the Keystone 65 Preferred HMO Provider/Pharmacy Directory 2017 Addendum to the Keystone 65 Preferred HMO Provider/Pharmacy Directory 2017 Changes as of February 2017 For the most up-to-date list of Keystone 65 Preferred HMO contracted providers and pharmacies, please visit www.ibxmedicare.com. You may also contact our Member Help Team at 1-800-645-3965 (TTY/TDD: 711) for assistance with choosing a provider or pharmacy. Representatives are available 7 days a week, from 8 a.m. to 8 p.m. However, please be aware that on weekends and holidays from February 15 to September 30, your call may be sent to voicemail. The pharmacy network, and/or provider network may change at any time. You will receive notice when necessary. Keystone 65 offers HMO plans with a Medicare contract. Enrollment in Keystone 65 Medicare Advantage plans depends on contract renewal. KS7911 (3/17) THE FOLLOWING PROVIDERS AND PHARMACIES HAVE JOINED THE KEYSTONE 65 PREFERRED HMO NETWORK. BERKS 2600 Paper Mill Road Raguckas, Christina M., HOME INFUSION CERTIFIED Wyomissing, PA 19610 DO PHARMACIES ANESTHESIOLOGY REGISTERED (610) 844-9150 NURSE ST JOSEPH MEDICAL HEALTHCARE SURGICAL INSTITUTE Leblanc, Leanne L., MD PRACTITIONER GROUP ST EVOLUTION, LLC P OF READING Singer, Gregory M., MD LAWRENCE MEDICAL 207 East Bellevue 003293102 RHPN INTERNAL MED ASSOCIATES 002996179 Avenue 2752 Century Boulevard 002817761 003379135 2600 Paper Mill Road Reading, PA 19605 Wyomissing, PA 19610 950A N Wyomissing 3970 Perkiomen Wyomissing, PA 19610 (610) 921-9700 (610) 372-8031 Boulevard Avenue, Suite 102 Wyomissing, PA 19610 (484) 220-0051 Drew, David M., DO Reading, PA 19606 INFERTILITY (610) 898-2400 Singer, Gregory M., MD (610) 779-1330 SHADY GROVE CARDIOVASCULAR Lampron, Heather L., PATIENT FIRST Gable, Meredith E., DO FERTILITY CENTER O DISEASE CRNP PENNSYLVANIA Mandel, Robert W., DO 002822929 READING HEALTH MEDICAL GROUP CHIROPRACTOR 1210 Broadcasting PHYSICIAN NETWORK 002822977 GASTROENTEROLO GY Road, Suite 101 003402591 TRI COUNTY 2600 Paper Mill Road Reading, PA 19610 1320 Broadcasting CHIROPRACTIC OF Wyomissing, PA 19610 READING HEALTH (610) 376-1229 Road, Suite 100 DOUGLASSVILLE (484) 220-0051 PHYSICIAN NETWORK Martin, Joseph R., MD Wyomissing, PA 19610 002818370 Hasan, Nadia, DO 002818621 (610) 375-6565 990 East Ben Franklin Patel, Trushna M., MD 301 South Seventh Highway INTERNAL MEDICINE Ahmad, Mussaber M., Rex, Sally A., DO Avenue, Suite 225 Douglassville, PA DO Singer, Gregory M., MD West Reading, PA PATIENT FIRST 19518 PENNSYLVANIA Chandler, Olivera, MD Suarez Kobilis, Monica 19611 (610) 382-1444 MEDICAL GROUP Diaz Fraga, Julian N., B., MD (610) 741-0310 Maybee, Daniel E., DC 002822977 MD Tohfafarosh, Nilofer J., Shin, Grace H., MD Lahoti, Ankush, MD MD 2600 Paper Mill Road FAMILY PRACTICE Modi, Danesh S., DO GENERAL SURGERY Wyomissing, PA 19610 SAINT JOSEPH LVPG FAMILY (484) 220-0051 MEDICAL GROUP RHPN TRAUMA 301 South 7th Avenue, MEDICINE HAMBURG Kim, David E., MD Suite 2020 003004968 002816239 002812248 Reading, PA 19611 2 Meridian Boulevard 420 S 5th Avenue READING HEALTH 700 Hawk Ridge Road (610) 375-6565 Wyomissing, PA 19610 West Reading, PA PHYSICIAN NETWORK Hamburg, PA 19526 Ahmad, Mussaber M., (610) 743-3139 19611 002813074 (610) 562-3066 DO Gable, Meredith E., DO (484) 628-4879 420 South 5th Avenue Greenberg, Grant M., Chandler, Olivera, MD Mandel, Robert W., DO Beard, Jessica H., MD West Reading, PA MD 19611 Diaz Fraga, Julian N., ST JOSEPH MEDICAL 003509417 (484) 628-5820 MD LVPG FAMILY GROUP MEDICINE KUTZTOWN 2607 Keiser Boulevard Champaneria, Vicky M., Lahoti, Ankush, MD 002818324 002813955 Wyomissing, PA 19610 MD Modi, Danesh S., DO 2494 Bernville Road, (610) 743-3139 Nesfeder, Jonathan M., 333 Norma Avenue Suite 200 31 Industrial Drive, Suite Schrenk, Jaime L., DO DO Kutztown, PA 19530 Reading, PA 19605 150 Palle, Vishnu V., MD (610) 683-8363 ST JOSEPH FAMILY (610) 378-7900 Hamburg, PA 19526 Sirisinahal, Sudhamshu, Mauro, Florence J., DO WOMENS CARE (610) 375-6565 McKenna, Kevin J., MD DO Ahmad, Mussaber M., PATIENT FIRST 002814271 DO MEDICAL GROUP 145 North 6th Street, 1st RHPN HOSPITALIST SERVICES Chandler, Olivera, MD 002822975 Floor 002813074 Lahoti, Ankush, MD Reading, PA 19601 Modi, Danesh S., DO (610) 378-2440 P - Preferred pharmacy 1 THE FOLLOWING PROVIDERS AND PHARMACIES HAVE JOINED THE KEYSTONE 65 PREFERRED HMO NETWORK. Sixth Avenue and TRHMC INTERNAL Heckman, Irene B., 4 S 4th Street, Floor 2 BERKS CNSLNG CTR Spruce Streets MEDICINE PRACTICE MSW Reading, PA 19602 INC West Reading, PA 002883382 002989514 716 N Park Rd (610) 743-5190 19611 301 South 7th Avenue, 645 Penn St Wyomissing, PA 19610 Cooper, Pierre V., MSW (610) 988-5455 Suite 340 Reading, PA 19601 (610) 375-0544 LESLIE M CHAUNDY Latycheva, Ekaterina, West Reading, PA (610) 373-4281 MD 19611 Heckman, Irene B., PSYD LLC MSW Messner, Linda J., MED Patel, Jay, MD (484) 628-8480 003488610 Nesfeder, Jonathan M., CONCERN PRO SVCS 2208 Quarry Dr Ste 200, CONCERN PRO SVCS 002813075 DO FOR CHILD YTH FML Van Reed Office Center FOR CHILD YTH FML 420 S 5th Avenue 002989400 Reading, PA 19609 002989400 West Reading, PA LACTATION 22 24 N Franklin Street (610) 563-2052 24 N Franklin St Ste 22 19611 CONSULTANT Fleetwood, PA 19522 Chapman, Julie, MA Fleetwood, PA 19522 (610) 988-8843 VICTORIA SULLIVAN (610) 944-0445 (610) 944-0445 Lombardi, Gilboa, MD MASTER LEVEL IBCLC RLC Everett, Susan L., MSW Rodriguez, Michael J., Shrestha, Rijesh R., MD THERAPIST - 003420181 MA CONCERN PRO SVCS PSYCHIATRIC/MENT 003434124 3933 Lynn Avenue FOR CHILD YTH FMLY AL HEALTH CONCERN PRO SVCS 420 South 5th Avenue Reading, PA 19606 FOR CHILD YTH FMLY 002989400 ALL ABOUT FAMILIES West Reading, PA (917) 742-2659 002989399 1 W Main St CNSLNG LLC 19611 Sullivan, Victoria F., 1120 Hobart Ave, Ste C Fleetwood, PA 19522 003522220 (484) 628-5455 RLC Wyomissing, PA 19610 (610) 944-0445 119 N Furnace St Baba, Murad, MD (610) 371-8035 LICENSED CLINICAL Carter, Erin E., MSW Birdsboro, PA 19508 Gan, Heng, MD Rodriguez, Michael J., SOCIAL WORKER Kunzmann, Lisa, MSW (610) 575-0390 Henrici, Meaghan, MD MA Gaughan, Kristen M., Johannesen, Justin, MD ALTRNTV CONSLTNG DGR MGMT INC MS 002989400 Khanal, Raju, MD ENTERPRISES INC 002989277 Huntzinger, Kristin A., 1 W Main St Parajuli, Prem R., MD 002989398 2201 Ridgewood Rd Ste MS Fleetwood, PA 19522 Parajuli, Rubina, MD 527 East Lancaster 400 (610) 944-0445 Pathak, Ranjan, MD Avenue Wyomissing, PA 19610 ASSOCS OF SPRINGFIELD Edris, Hillary R., MA Reed, Ashley K., MD Shillington, PA 19607 (610) 378-9601 PSYCHL Rodriguez, Michael J., (610) 796-8110 Volo, Naomi, MSW MA 6th Avenue and Spruce Modesto, Salvatore S., 002989038 Street GLAD SVCS CNSLNG MSW 2909 Windmill Road 1120 Hobart Avenue, AND COACHING CTR West Reading, PA Sinking Spring, PA Suite C 19611 BERKS CNSLNG 003315388 19608 Wyomissing, PA 19610 (484) 628-5455 ASSOCSPC 4 Wellington Boulevard (610) 544-2110 (610) 371-8035 Panchal, Maulik D., MD 002989721 Wyomissing, PA 19610 Lambert, Olivia, MS Edris, Hillary R., MA Seda Lopez, Jean C., 1150 Berkshire Blvd, Ste (610) 678-7300 250 BERKS CNSLNG Rodriguez, Michael J., MD Kennedy Hassel, Linda ASSOCSPC MA Wyomissing, PA 19610 A., MSW ST JOSEPH MEDICAL (610) 373-7005 002989721 DGR MGMT INC GROUP HORIZONZ LLC Jackson, Nikol, MSW 1150 Berkshire Blvd, Ste 002989277 002818324 002989596 250 2201 Ridgewood Rd Ste 2500 Bernville Rd BERKSHIRE PSYCHC 230 N 5th St, Ste 310 Wyomissing, PA 19610 400 Reading, PA 19605 002988924 Reading, PA 19601 (610) 373-7005 Wyomissing, PA 19610 (610) 378-2000 640 Walnut St Ste 303 (610) 743-5190 Huntzinger, Kristin A., (610) 378-9601 Decolli, Robert A., DO Reading, PA 19601 MS Cooper, Pierre V., MSW Henchinski, Kimberly A., (610) 208-8860 MFT P - Preferred pharmacy 2 THE FOLLOWING PROVIDERS AND PHARMACIES HAVE JOINED THE KEYSTONE 65 PREFERRED HMO NETWORK. FMLY GUIDNC CTR NEUROLOGY NURSE MIDWIFE RHPN WOMENS OPTOMETRIST 002988906 CLINIC AND IVF RHPN READING HEALTH WYOMISSING 1235 Penn Ave Ste 205 FERTILITY NEUROLOGICAL PHYSICIAN NETWORK OPTOMETRIC 206 002996858 CRITICAL CARE 002813569 CENTER Wyomissing, PA 19610 301 S Seventh Ave, 003506740 6th Avenue and Spruce 002803854 (610) 374-4963 Suite 245 420 S 5th Avenue Street, The Reading 1050 Ben Frankiln Rimby, Jamie L., BSW Reading, PA 19611 West Reading, PA Hospital and Medical Highway West HOLCOMB BHVRL 19611 Center (484) 628-7000 Douglassville, PA HLTH SYST (484) 628-6255 West Reading, PA Grassi, Anna M., DO 19518 19611 002989124 Shah, Jharna N., MD ST JOSEPH MEDICAL (610) 385-4333 1011 Reed Ave Ste 900 (610) 988-8827 GROUP Umlauf, Perry C., OD RHPN NEUROLOGY Wyomissing, PA 19610 Davison, Beth A., CNM 002818324 002815999 50 Berkshire Court, (610) 939-9999 2494 Bernville Road, 301 South Seventh Ave, 003004823 Berkshire Court Getz, Tari L., MED Ste 100 Ste 210 949 New Holland Rd Professional Build Reading, PA 19605 LESLIE M CHAUNDY West Reading, PA Reading, PA 19607 Wyomissing, PA 19610 PSYD LLC 19611 (484) 628-2030 (610) 378-2899 (610) 374-3134 003488610 (484) 628-4656 Sanner, Marissa J., Davies, Matthew F., MD Umlauf, Perry C., OD 2208 Quarry Dr Ste 200, Khurana, Jasdeep K., CNM 2500 Bernville Rd Van Reed Office Center MD ORTHOPEDIC RHPN READING OB Reading, PA 19605 SURGERY Reading, PA 19609 Lovinger, Joshua N., MD GYN (610) 378-2000 (610) 563-2052 ST JOSEPH MEDICAL RPS TRAUMA 003004823 Davies, Matthew F., MD GROUP Gillette, Heather P., MA CENTER 3701 Perkiomen Avenue OCCUPATIONAL 002818324 PA CNSLNG SVCS INC 002816239 Reading, PA 19606 THERAPIST 2500 Bernville Rd 002988888 6th Avenue and Spruce (484) 628-2220 Reading, PA 19605 125 S 5th St Street, The Reading Sanner, Marissa J.,
Load more

Recommended publications
  • P&G 2010 Annual Report
    Touching & Improving Lives 2010 ANNUAL REPORT Net Sales Contents ($ billions) Letter to Shareholders 1 10 $78.9 Leadership Brands 7 Touching & Improving Lives 11 09 $76.7 More Consumers 12 08 $79.3 More Parts of the World 16 07 $72.4 More Completely 20 06 $64.4 P&G Innovations 24 Making a Difference 26 Financial Contents 27 Global Leadership Council 75 Operating Cash Flow Board of Directors 75 ($ billions) Financial Summary 76 Company and Shareholder Information 78 10 $16.1 09 $14.9 08 $15.0 07 $13.4 06 $11.4 Diluted Net Earnings (per common share) 10 $4.11 09 $4.26 08 $3.64 07 $3.04 06 $2.64 2010 Net Sales By business segment By geographic region By market maturity (% of total business segments) 15% 34% Beauty & Grooming 9% North America 34% Developed Health and Well-Being 42% Western Europe 48% Developing Household Care 13% Central & Eastern Europe, 66% Middle East & Africa 18% These results exclude net sales in Corporate. 21% Latin America Asia Financial Highlights (unaudited) Amounts in millions, except per share amounts 2010 2009 2008 2007 2006 Net Sales $78,938 $76,694 $79,257 $72,441 $64,416 Operating Income 16,021 15,374 15,979 14,485 12,551 Net Earnings 12,736 13,436 12,075 10,340 8,684 Net Earnings Margin from Continuing Operations 13.9% 13.9% 14.2% 13.3% 12.7% Diluted Net Earnings per Common Share from Continuing Operations $ 3.53 $ 3.39 $ 3.40 $ 2.84 $ 2.49 Diluted Net Earnings Per Common Share 4.11 4.26 3.64 3.04 2.64 Dividends Per Common Share 1.80 1.64 1.45 1.28 1.15 Dear Shareholders, P&G’s Purpose–to touch and improve lives, now and for generations to come–is inspiring and pervasive.
    [Show full text]
  • Procter & Gamble Co (Pg)
    PROCTER & GAMBLE CO (PG) 10-K Annual report pursuant to section 13 and 15(d) Filed on 08/08/2012 Filed Period 06/30/2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2012 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 Telephone (513) 983-1100 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock, without Par Value New York Stock Exchange, NYSE Euronext-Paris Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes þ No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No þ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • Sustainability Report Contents Introduction 2020 Goals Progress P&G Profile Environmental Sustainability Social Responsibility GRI Index 2 of 75
    Contents Introduction 2020 Goals Progress P&G Profile Environmental Sustainability Social Responsibility GRI Index 1 of 75 2015 Sustainability Report Contents Introduction 2020 Goals Progress P&G Profile Environmental Sustainability Social Responsibility GRI Index 2 of 75 Environmental and social responsibility are part of everyone’s job at P&G. They are integrated into our daily work and business operations. DAVID S. TAYLOR President and Chief Executive Officer NOTE TO PDF USER This PDF utilizes interactive elements. Click on contents and hyperlinks for easy navigation. ABOUT OUR 17TH ANNUAL SUSTAINABILITY REPORT This is the 17th Sustainability Report for Procter & Gamble’s worldwide operations. Data in this report cover the period from July 1, 2014, through June 30, 2015. Financial information is given in U.S. dollars. This report was prepared using the Global Reporting Initiative’s (GRI’s) G3 Reporting Guidelines. The mission of the GRI is to promote international harmonization in the reporting of relevant and credible corporate economic, environmental and social performance information to enhance responsible decision making. The GRI has not verified the contents of this report, nor does it take a position on the reliability of information reported herein. For further information about the GRI, For the latest P&G news, in-depth information on P&G’s brands, and please visit: www.globalreporting.org shareholder and career information, please visit: www.pg.com Contents Contents Introduction 2020 Goals Progress P&G Profile Environmental
    [Show full text]
  • P&G 2016 Annual Report
    P&G 2016 Annual Report FINANCIAL HIGHLIGHTS (UNAUDITED) NET SALES ($ BILLIONS) Amounts in billions, except per share amounts 2016 $65.3 2015 $70.7 2016 2015 2014 2013 2012 2014 $74.4 Net sales $65.3 $70.7 $74.4 $73.9 $73.1 2013 $73.9 2012 $73.1 Operating income 11.0 13.9 13.1 12.5 13.4 OPERATING CASH FLOW ($ BILLIONS) 2016 $15.4 Net earnings attributable 7.0 11.6 11.3 10.8 to Procter & Gamble 10.5 2015 $14.6 2014 $14.0 Net earnings margin from 2013 $14.9 % 11.7% 14.3% 14.0% 12.1% continuing operations 15.4 2012 $13.3 Diluted net earnings per common share from $ $2.84 $3.63 $3.50 $2.97 DILUTED NET EARNINGS (PER COMMON SHARE) continuing operations(1) 3.49 2016 $3.69 Diluted net earnings per 2.44 4.01 3.86 3.66 2015 $2.44 common share(1) 3.69 2014 $4.01 2013 $3.86 Dividends per $ $2.59 $2.45 $2.29 $2.14 common share 2.66 2012 $3.66 2016 NET SALES BY BUSINESS SEGMENT(2) 2016 NET SALES BY MARKET MATURITY Grooming 11% Baby, Feminine 28% and Family Care Health Care 11% Developing 35% 65% Developed Markets Markets Fabric and 18% Beauty Home Care 32% 2016 NET SALES BY GEOGRAPHIC REGION Europe 23% North America Greater China 44% 8% Latin America Asia Pacific India, % Middle East % 8 & Africa (IMEA) 9 8% (1) Diluted net earnings per common share are calculated based on net earnings attributable to Procter & Gamble.
    [Show full text]
  • PG 10-K 6/30/2014 Section 1: 10-K (10-K)
    PG 10-K 6/30/2014 Section 1: 10-K (10-K) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2014 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 Telephone (513) 983-1100 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock, without Par Value New York Stock Exchange, NYSE Euronext-Paris Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes þ No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No þ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
    [Show full text]
  • Cedar Mill Business News
    Like us on Facebook FREE for timely updates Sign up to get The News online: Cedar Mill News cedarmillnews.com/ Volume 12, Issue 4 April 2014 signup Featured Business He says that his experience with Another close call on Saltzman Pest Solutions LLC Milltown has helped him a lot in by Virginia Bruce fire were dispatched and the road By Virginia Bruce his new venture. “As a stockbroker, Neighbor and eyewitness Eliot was closed, with one line crossing Eric Ufer says his company, Pest I was more on my own. Working Sluyter reported, “During the Saltzman, one pole leaning into the Solutions LLC., “ex- with 30 volunteers and morning of April 1, a semi truck road, and one long line hanging ists to protect people hundreds of coaches hauling large equipment on a trailer into the road at eye-level.” and property, while in the club taught me came around the corner at the top Sluyter continued, “Earlier that being as green as can how to delegate, and of the Saltzman hill, heading north week, either the evening of March be.” They achieve that how to get people to (down the hill). A car goal by going beyond accept accountabil- was heading south (up the typical arsenal of ity for their work,” he the hill) either cutting poisons and “out of says. And one of his the corner or simply the box” remedies, associates at Milltown, staying in its lane. and studying the sci- Lisa Draper, is now his Either way, there was ence behind each pest problem. “We Office Manager.
    [Show full text]
  • MEDICINE Bufall 2019 • Volume 104Et • Number 2 In
    MEDICINE BuFall 2019 • Volume 104et • Number 2 in A Bold New Vision on BLOOD RESEARCH #1 in Maryland and TOP 10 in the nation for Ear, Nose and Throat Pictured left to right: Nidhi Gupta, MD; John F. Biedlingmaier, MD; Rodney J. Taylor, MD; Kyle Monroe Hatten, MD; David J. Eisenman, MD; Kalpesh Tarun Vakharia, MD; Kevin D. Pereira, MD; Jeffrey S. Wolf, MD, FACS; Amal Isaiah, MD, PhD; Elizabeth Anne Guardiani, MD Not pictured above: The Otorhinolaryngology – Head & Neck Surgery program at University of Maryland Medical Center leads in advanced Ronna P. Hertzano, MD, PhD care. The department provides expertise in conditions that span pediatric disorders, voice and swallowing difficulties, ear disease and hearing loss, sinus and allergic disease, plastic and reconstructive surgery and head and neck neoplasms. The team continually improves surgical care for Andrea Michelle Hebert, MD head and neck tumors by increasingly employing transoral robotic surgery (TORS) and the endoscopic endonasal approach (EEA). These minimally invasive approaches result in less morbidity, easier recoveries and better cosmesis for patients. From innovative research to better understand the molecular basis of congenital and acquired hearing loss, to studying the ZSCAN4 gene in hopes of targeting cancer cells and advance regenerative medicine on a larger scale, the Otorhinolaryngology – Head & Neck Surgery program is pioneering advancements in the field. Learn more at umm.edu/ent Visit our Physician Video Channel at physicians.umm.edu Affiliated with the University of Maryland School of Medicine Bulletin Editorial Board MEDICINE Harry C. Knipp, ’76 Chairman Gary D. Plotnick, ’66 Vice Chairman John Allen, ’14 Frank M.
    [Show full text]
  • Summit Partners to Acquire MDVIP
    Source: Summit Partners May 02, 2014 08:33 ET Summit Partners to Acquire MDVIP National Leader in Personalized Preventive Healthcare Continues Rapid Growth BOSTON, MA--(Marketwired - May 2, 2014) - Growth equity investor Summit Partners today announced that it has entered into an agreement to acquire MDVIP from The Procter & Gamble Company (NYSE: PG). The agreement is expected to close shortly subject to standard regulatory approvals. Additional terms of the investment are not being disclosed. Founded in 2000, MDVIP is the nation's largest national network of physicians and patients in personalized preventive healthcare. The company serves more than 700 MDVIP-affiliated primary care physicians with more than 200,000 patients nationally. MDVIP offers physicians and members an alternative to the traditional primary healthcare deliver model by enabling members to have an enhanced relationship with their primary care physician. MDVIP's approach to primary care places the emphasis on "wellness" care, not just "sick" care. Summit Partners originally invested in MDVIP in 2004 and sold the company to P&G in 2009. Patient membership in MDVIP practices has nearly doubled in the past four years and expanded across the United States. P&G said the sale of MDVIP is another step in its strategy to focus the company's portfolio on core businesses where P&G can create the most value for consumers and shareowners. The transaction creates value for P&G shareowners, and P&G is confident that Summit Partners will provide strong leadership as an investor to support the needs and advance the goals of the MDVIP national network.
    [Show full text]
  • Equity Research Department
    January 20, 2011 Equity Research Procter & Gamble Co. PG: Initiated Coverage With Outperform Rating, $70-73 Valuation Outperform D&E Opportunities Should Drive Top-Line, Op Mgn, And EPS Growth • Summary: We have initiated coverage of PG with an Outperform rating on the Sector: Household and Personal Care shares and a $70-73 valuation range. Our rating within our Market Weight Products Household and Personal Care sector rating is based on (1) P&G's industry- Market Weight leading research and development (R&D) investments, (2) penetration acceleration in developing and emerging (D&E) markets (i.e., more relative runway versus competitors), and (3) leveraging of both scale and financial Initiation of Coverage strength to increase earnings. Near-term gross margin will likely be restrained by rising input costs. Long-term gross or operating margin expansion will likely 2010A 2011E 2012E be driven by ongoing cost-saving initiatives, improving business and product EPS Curr. Prior Curr. Prior mix, and leveraging of distribution expansion. P&G's portfolio provides a Q1 (Sep.) $0.97 $1.02 A NC$1.13NE competitive advantage with (1) broad exposure to fast-growing categories, Q2 (Dec.) 1.10 1.10 NE 1.20 NE (2) strong margin from scale in market-leading brands, and (3) efficiency Q3 (Mar.) 0.89 1.00 NE 1.11 NE entering D&E markets. P&G will likely continue to make small to midsize Q4 (June) 0.71 0.86 NE 0.95 NE accretive acquisitions. Current valuations on our 2012 estimates are 31% and FY $3.67 $3.98 NE $4.39 NE CY $3.72 $4.19 $4.61 27% below and above the low end of historical P/E and enterprise value (EV)-to- FY P/E 17.8x 16.4x 14.9x EBITDA ranges.
    [Show full text]
  • Download the Complete P&G 2011 Annual Report
    2011 ANNUAL REPORT Innovating for Everyday Life Contents Letter to Shareholders................................. 1 Crest 3D White ......................................20 Financial Contents ....................................29 Leadership Brands .......................................9 Gain Dishwashing Liquid ........................22 Global Leadership Council .........................75 Innovating for Everyday Life ......................14 Head & Shoulders ..................................24 Board of Directors .....................................75 Gillette Guard ........................................ 16 Old Spice ...............................................26 Financial Summary ....................................76 Brazil ...................................................... 18 Disaster Relief ...........................................28 Company and Shareholder Information.....78 Net Sales ($ billions) Operating Cash Flow ($ billions) Diluted Net Earnings (per common share) 11 $82.6 11 $13.2 11 $3.93 10 $78.9 10 $16.1 10 $4.11 09 $76.7 09 $14.9 09 $4.26 08 $79.3 08 $15.0 08 $3.64 07 $72.4 07 $13.4 07 $3.04 2011 Net Sales By business segment By geographic region By market maturity 16% 19% 24% Beauty North America Developed Grooming 9% Western Europe Developing 9% Health Care 41% Central & Eastern Europe, 35% 65% Middle East & Africa Snacks & Pet Care 14% 30% Latin America 14% Fabric Care & Home Care Asia 4% Baby Care & Family Care 20% Financial Highlights (unaudited) Amounts in millions, except per share amounts 2011 2010 2009 2008 2007 Net Sales $82,559 $78,938 $76,694 $79,257 $72,441 Operating Income 15,818 16,021 15,374 15,979 14,485 Net Earnings 11,797 12,736 13,436 12,075 10,340 Net Earnings Margin from Continuing Operations 14.3% 13.9% 13.9% 14.2% 13.3% Diluted Net Earnings per Common Share from Continuing Operations $3.93 $3.53 $3.39 $3.40 $2.84 Diluted Net Earnings Per Common Share 3.93 4.11 4.26 3.64 3.04 Dividends Per Common Share 1.97 1.80 1.64 1.45 1.28 Robert A.
    [Show full text]
  • The Procter & Gamble Company
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 31, 2010 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 31-0411980 (State of Incorporation) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrant’s telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
    [Show full text]
  • 2014 Sustainability Report 2 of 68
    1 of 68 2014 Sustainability Report 2 of 68 At P&G, sustainability is part of NOTE TO PDF USER This PDF utilizes interactive elements. Click on contents and hyperlinks everything we do. for easy navigation. - A.G. Lafley, P&G President, CEO and Chairman of the Board ABOUT THIS PUBLICATION This is the 16th Sustainability Report for Procter & Gamble’s worldwide operations. Data in this report cover the period from July 1, 2013, through June 30, 2014. Financial information is given in U.S. dollars. This report was prepared using the Global Reporting Initiative’s (GRI) G3 Reporting Guidelines. The mission of the GRI is to promote international harmonization in the reporting of relevant and credible corporate economic, environmental and social performance information to enhance responsible decision making. The GRI has not verified the contents of this report, nor does it take a position on the reliability of information reported herein. For further information about the GRI, For the latest P&G news, in-depth information please visit: www.globalreporting.org on P&G’s brands and shareholder and career information, please visit: www.pg.com Contents 3 of 68 Contents . 3 Environmental Sustainability . 26 Social Responsibility . 43 Conservation of Resources ..............27 Social Responsibility Programs ...........44 Introduction . 4 Cold-Water Washing ................27 Comforts of Home .................44 Leadership Statement ................4 Packaging Reduction ................28 Health and Hygiene .................45 Our Goals .........................5
    [Show full text]